These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 22322891)
1. Effect of the antitumoral alkylating agent 3-bromopyruvate on mitochondrial respiration: role of mitochondrially bound hexokinase. Rodrigues-Ferreira C; da Silva AP; Galina A J Bioenerg Biomembr; 2012 Feb; 44(1):39-49. PubMed ID: 22322891 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate. Pereira da Silva AP; El-Bacha T; Kyaw N; dos Santos RS; da-Silva WS; Almeida FC; Da Poian AT; Galina A Biochem J; 2009 Feb; 417(3):717-26. PubMed ID: 18945211 [TBL] [Abstract][Full Text] [Related]
3. 3-Bromopyruvate regulates the status of glycolysis and BCNU sensitivity in human hepatocellular carcinoma cells. Sun X; Sun G; Huang Y; Hao Y; Tang X; Zhang N; Zhao L; Zhong R; Peng Y Biochem Pharmacol; 2020 Jul; 177():113988. PubMed ID: 32330495 [TBL] [Abstract][Full Text] [Related]
4. Mitochondria-Bound Hexokinase (mt-HK) Activity Differ in Cortical and Hypothalamic Synaptosomes: Differential Role of mt-HK in H Cavalcanti-de-Albuquerque JP; de Souza Ferreira E; de Carvalho DP; Galina A Mol Neurobiol; 2018 Jul; 55(7):5889-5900. PubMed ID: 29119535 [TBL] [Abstract][Full Text] [Related]
5. Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma. Kim W; Yoon JH; Jeong JM; Cheon GJ; Lee TS; Yang JI; Park SC; Lee HS Mol Cancer Ther; 2007 Sep; 6(9):2554-62. PubMed ID: 17876052 [TBL] [Abstract][Full Text] [Related]
6. Role of reactive oxygen species-mediated mitochondrial dysregulation in 3-bromopyruvate induced cell death in hepatoma cells : ROS-mediated cell death by 3-BrPA. Kim JS; Ahn KJ; Kim JA; Kim HM; Lee JD; Lee JM; Kim SJ; Park JH J Bioenerg Biomembr; 2008 Dec; 40(6):607-18. PubMed ID: 19067133 [TBL] [Abstract][Full Text] [Related]
7. [Expression of hexokinase-II gene in human colon cancer cells and the therapeutic significance of inhibition thereof]. Peng QP; Liang HJ; Zhou Q; Zhou JM; Fu XL; Zhong DP Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1058-62. PubMed ID: 17672972 [TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen species production by potato tuber mitochondria is modulated by mitochondrially bound hexokinase activity. Camacho-Pereira J; Meyer LE; Machado LB; Oliveira MF; Galina A Plant Physiol; 2009 Feb; 149(2):1099-110. PubMed ID: 19109413 [TBL] [Abstract][Full Text] [Related]
9. 3-Bromopyruvate Attenuates Experimental Pulmonary Hypertension via Inhibition of Glycolysis. Zhang YL; Zhang R; Shen YF; Huang KY; He YY; Zhao JH; Jing ZC Am J Hypertens; 2019 Mar; 32(4):426-432. PubMed ID: 30561502 [TBL] [Abstract][Full Text] [Related]
10. 3-Bromopyruvic Acid Inhibits Tricarboxylic Acid Cycle and Glutaminolysis in HepG2 Cells. Jardim-Messeder D; Moreira-Pacheco F Anticancer Res; 2016 May; 36(5):2233-41. PubMed ID: 27127128 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial bound hexokinase activity as a preventive antioxidant defense: steady-state ADP formation as a regulatory mechanism of membrane potential and reactive oxygen species generation in mitochondria. da-Silva WS; Gómez-Puyou A; de Gómez-Puyou MT; Moreno-Sanchez R; De Felice FG; de Meis L; Oliveira MF; Galina A J Biol Chem; 2004 Sep; 279(38):39846-55. PubMed ID: 15247300 [TBL] [Abstract][Full Text] [Related]
12. 3-Bromopyruvate induces apoptosis in breast cancer cells by downregulating Mcl-1 through the PI3K/Akt signaling pathway. Liu Z; Zhang YY; Zhang QW; Zhao SR; Wu CZ; Cheng X; Jiang CC; Jiang ZW; Liu H Anticancer Drugs; 2014 Apr; 25(4):447-55. PubMed ID: 24492287 [TBL] [Abstract][Full Text] [Related]
13. Energy metabolism in H460 lung cancer cells: effects of histone deacetylase inhibitors. Amoêdo ND; Rodrigues MF; Pezzuto P; Galina A; da Costa RM; de Almeida FC; El-Bacha T; Rumjanek FD PLoS One; 2011; 6(7):e22264. PubMed ID: 21789245 [TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor activity of 3-bromopyruvate in combination with rapamycin in vivo and in vitro. Zhang Q; Pan J; Lubet RA; Komas SM; Kalyanaraman B; Wang Y; You M Cancer Prev Res (Phila); 2015 Apr; 8(4):318-26. PubMed ID: 25644152 [TBL] [Abstract][Full Text] [Related]
15. Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate. Chen Z; Zhang H; Lu W; Huang P Biochim Biophys Acta; 2009 May; 1787(5):553-60. PubMed ID: 19285479 [TBL] [Abstract][Full Text] [Related]
16. 3-Bromopyruvic acid, a hexokinase II inhibitor, is an effective antitumor agent on the hepatoma cells : in vitro and in vivo findings. Gong L; Wei Y; Yu X; Peng J; Leng X Anticancer Agents Med Chem; 2014 Jun; 14(5):771-6. PubMed ID: 24738957 [TBL] [Abstract][Full Text] [Related]
17. Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy. Mathupala SP; Ko YH; Pedersen PL Semin Cancer Biol; 2009 Feb; 19(1):17-24. PubMed ID: 19101634 [TBL] [Abstract][Full Text] [Related]
18. Glycolytic inhibition by 3-bromopyruvate increases the cytotoxic effects of chloroethylnitrosoureas to human glioma cells and the DNA interstrand cross-links formation. Sun X; Sun G; Huang Y; Zhang S; Tang X; Zhang N; Zhao L; Zhong R; Peng Y Toxicology; 2020 Apr; 435():152413. PubMed ID: 32109525 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of energy metabolism by 3-bromopyruvate in the hard tick Rhipicephalus microplus. Braz V; Gomes H; Galina A; Saramago L; Braz G; da Silva Vaz I; Logullo C; da Fonseca RN; Campos E; Moraes J Comp Biochem Physiol C Toxicol Pharmacol; 2019 Apr; 218():55-61. PubMed ID: 30580107 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of 3-bromopyruvate in human nasopharyngeal carcinoma cells. Zou X; Zhang M; Sun Y; Zhao S; Wei Y; Zhang X; Jiang C; Liu H Oncol Rep; 2015 Oct; 34(4):1895-904. PubMed ID: 26239511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]